Pelican Unveils Aegis 25L Tactical Backpack in Limited-Edition MultiCam® at SHOT Show 2026

The newest addition to the Aegis ecosystem is engineered for tactical enthusiasts Pelican, the global leader in mission-critical protective solutions, today announced the launch of the Aegis(TM) 25L Tactical Backpack, debuting exclusively at SHOT Show 2026 (January 20-23). Designed for tactical enthusiasts, competitive shooters, and off-duty professionals, the Aegis(TM) 25L will be available in a […]

$100M-Backed EDENA Capital Partners Unveils Global Vision at New York Stock Exchange

New York, NY , Jan. 13, 2026 (GLOBE NEWSWIRE) — EDENA Capital Partners, a digital securities infrastructure company focused on emerging markets, made its New York Stock Exchange debut following its recent announcement of a $100 million institutional investment from Global Emerging Markets (GEM). GEM is sponsored by GEM Group, a $3.4 billion alternative investment

$100M-Backed EDENA Capital Partners Unveils Global Vision at New York Stock Exchange

$100M-Backed EDENA Capital Partners Unveils Global Vision at New York Stock Exchange GlobeNewswire January 13, 2026 New York, NY , Jan. 13, 2026 (GLOBE NEWSWIRE) — EDENA Capital Partners, a digital securities infrastructure company focused on emerging markets, made its New York Stock Exchange debut following its recent announcement of a $100 million institutional investment

DEFENSE UNICORNS RAISES $136 MILLION SERIES B TO BUILD THE SOFTWARE BACKBONE OF THE DEPARTMENT OF WAR

Reaching a $1B valuation underscores Defense Unicorns’ role as modern foundational infrastructure for secure software delivery across critical military platforms. Today, Defense Unicorns, the leader in airgap software delivery for national security mission systems, announced the completion of a $136 million Series B financing round led by Bain Capital. The investment brings the company to

Britannica Studio: The AI Workspace Teachers Can Actually Trust

Content is drawn from company’s reliable and thoroughly vetted sources Britannica Education today announced Britannica Studio, a teacher-first artificial-intelligence workspace that helps educators quickly turn Britannica’s verified, standards-aligned content into classroom-ready materials without sacrificing accuracy, rigor or time. AI Teachers Can Trust, Built for the Way They Work Britannica Studio arrives at a time when

Leo International Group Relocates Global Headquarters to Singapore Ahead of Its Centennial

Embodying a New Model of Inter-generational Enterprise Anchored in Healthcare, Finance and Education As Leo International Group approaches its centennial year in 2026, the Group is not merely commemorating a hundred years of legacy and commercial success. With the formal relocation of its global headquarters to Singapore and the planned inauguration of its Family Office,

IN TWO WEEKS: Student Voices to Take the Spotlight at North Dakota Capitol School Choice Event

Students and educators to celebrate educational options during School Choice Week Hundreds of students, parents, and teachers will be at the Capitol in Bismarck on Tuesday, Jan. 27 to celebrate school choice in North Dakota. The event, organized and hosted by American Experiment North Dakota and co-hosted by Americans for Prosperity North Dakota and EdChoice

Treace Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2025 Revenue

(NASDAQ:TMCI), PONTE VEDRA, Fla., Jan. 13, 2026 (GLOBE NEWSWIRE) — Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today announced its preliminary, unaudited fourth quarter and full-year 2025 revenue results. Highlights: Preliminary revenue of $62.1

Sight Sciences Announces Preliminary, Unaudited Fourth Quarter and Full Year 2025 Financial Highlights

(NASDAQ:SGHT), MENLO PARK, Calif., Jan. 13, 2026 (GLOBE NEWSWIRE) — Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing innovative, interventional technologies intended to transform care and improve patients' lives, today reported select preliminary, unaudited financial highlights for the fourth quarter and full year ended

Boehringer Ingelheim advances potential first-in-class IL-11 inhibitor to Phase II Clinical Research in Idiopathic Pulmonary Fibrosis

Not intended for US and UK audiences BI 765423 has been developed to target IL-11, a key driver of fibrosis New study will investigate potential of BI 765423 to improve lung function for patients with idiopathic pulmonary fibrosis (IPF) Ingelheim, Germany, 13 January 2026 – Boehringer Ingelheim today announced the start of a Phase IIa

Scroll to Top